Case
... respect for persons, which is a fundamental principle of all morality. Respect for persons affirms that each and every person has moral value and dignity in his or her own right. In this sense, the principle of respect applies to every ...
... respect for persons, which is a fundamental principle of all morality. Respect for persons affirms that each and every person has moral value and dignity in his or her own right. In this sense, the principle of respect applies to every ...
SUNY Buffalo Department of Family Medicine
... 15. Demonstrate proficiency in facilitating health behavior change, including the ability to: Assess the patient's readiness for change, if behavior change is recommended. Customize the behavior change plan to suit the patient's readiness to change, the patient's perspective on their problem and ...
... 15. Demonstrate proficiency in facilitating health behavior change, including the ability to: Assess the patient's readiness for change, if behavior change is recommended. Customize the behavior change plan to suit the patient's readiness to change, the patient's perspective on their problem and ...
nhs tayside - My Dundee
... If someone has a learning disability it means that they may not learn things as quickly as other people and they may need more help and support to learn. Learning disability is not an illness. It is a permanent condition, but with the right kind of help many people can acquire practical and social s ...
... If someone has a learning disability it means that they may not learn things as quickly as other people and they may need more help and support to learn. Learning disability is not an illness. It is a permanent condition, but with the right kind of help many people can acquire practical and social s ...
Heart Rhythm Disturbances Associated With Rupatadine
... for the older ones. The case of torsade de pointes included in this study has been described in detail elsewhere.8 Some of these adverse reactions are cause for concern because these drugs are commonly used for prolonged periods to treat a great number of patients with a wide range of conditions who ...
... for the older ones. The case of torsade de pointes included in this study has been described in detail elsewhere.8 Some of these adverse reactions are cause for concern because these drugs are commonly used for prolonged periods to treat a great number of patients with a wide range of conditions who ...
FAQs: Frequently asked questions about inpatient diabetes
... Q. How should HYPERGLYCAEMIA in hospital be prevented and treated? Treatment of hyperglycaemia in hospitalised patients depends upon the type of diabetes, the patient's current blood glucose levels, prior treatment, the clinically assessed severity of illness, and the expected caloric intake during ...
... Q. How should HYPERGLYCAEMIA in hospital be prevented and treated? Treatment of hyperglycaemia in hospitalised patients depends upon the type of diabetes, the patient's current blood glucose levels, prior treatment, the clinically assessed severity of illness, and the expected caloric intake during ...
Characteristics and clinical course of patients with acute heart failure
... of hospitalization and represents a major economic and medical burden in any public health system. It is associated with increased hospital mortality after discharge, as well as high rates of readmission1. The diagnosis, management and treatment of AHF in routine clinical practice is based on data f ...
... of hospitalization and represents a major economic and medical burden in any public health system. It is associated with increased hospital mortality after discharge, as well as high rates of readmission1. The diagnosis, management and treatment of AHF in routine clinical practice is based on data f ...
PR BEZALIP SR
... hyperlipidemia with type IIb and type IV hyperlipoproteinemia. Initial therapy for dyslipidemia should include at least an equivalent of the American Heart Association (AHA) step 1 diet. There is evidence from coronary angiographic studies to show that triglyceride-rich lipoproteins are an important ...
... hyperlipidemia with type IIb and type IV hyperlipoproteinemia. Initial therapy for dyslipidemia should include at least an equivalent of the American Heart Association (AHA) step 1 diet. There is evidence from coronary angiographic studies to show that triglyceride-rich lipoproteins are an important ...
Gilenya - Novartis Pharmaceuticals Corporation
... should be available. Consider suspending treatment with GILENYA if a patient develops a serious infection, and reassess the benefits and risks prior to reinitiation of therapy. Because the elimination of fingolimod after discontinuation may take up to 2 months, continue monitoring for infections thr ...
... should be available. Consider suspending treatment with GILENYA if a patient develops a serious infection, and reassess the benefits and risks prior to reinitiation of therapy. Because the elimination of fingolimod after discontinuation may take up to 2 months, continue monitoring for infections thr ...
oral direct thrombin inhibitors
... These drugs inhibit factor Xa, in the final common pathway of clotting . These drugs are given as fixed doses and do not require monitoring. They have a rapid onset of action and shorter half-lives than warfarin (approximately 10 hours but half-life may be prolonged in elderly patients or those with ...
... These drugs inhibit factor Xa, in the final common pathway of clotting . These drugs are given as fixed doses and do not require monitoring. They have a rapid onset of action and shorter half-lives than warfarin (approximately 10 hours but half-life may be prolonged in elderly patients or those with ...
Prescribing of COX-2 inhibitors in Germany after safety warnings
... prescribing due to unwanted side effects (Arzneimittelkommission der Deutschen rzteschaft 2006; Schoenhofer et al. 2003; The International Agranulocytosis and Aplastic Anemia Study Group 1986). Moreover, according to guidelines, metamizol is explicitly not to be used in chronic inflammatory disease ...
... prescribing due to unwanted side effects (Arzneimittelkommission der Deutschen rzteschaft 2006; Schoenhofer et al. 2003; The International Agranulocytosis and Aplastic Anemia Study Group 1986). Moreover, according to guidelines, metamizol is explicitly not to be used in chronic inflammatory disease ...
PNH Research Summary - Aplastic Anemia and MDS
... mutation in the PIG-A gene. At least half of the patients with aplastic anemia in the United Kingdom have a PNH clone. There is little evidence to guide treatment of both aplastic anemia and PNH in the same patient. The investigators reviewed data on 26 patients (median age 40 years) with aplastic a ...
... mutation in the PIG-A gene. At least half of the patients with aplastic anemia in the United Kingdom have a PNH clone. There is little evidence to guide treatment of both aplastic anemia and PNH in the same patient. The investigators reviewed data on 26 patients (median age 40 years) with aplastic a ...
Immunotherapy and Lymphoma - Lymphoma Research Foundation
... chemotherapy–orally (pill taken by mouth), subcutaneously (injection under the skin), or intravenously (injection directly into a vein). Immunotherapy drugs may even be given with chemotherapy, such as in the R-CHOP regimen (rituximab [Rituxan], cyclophosphamide, doxorubicin, vincristine, prednisone ...
... chemotherapy–orally (pill taken by mouth), subcutaneously (injection under the skin), or intravenously (injection directly into a vein). Immunotherapy drugs may even be given with chemotherapy, such as in the R-CHOP regimen (rituximab [Rituxan], cyclophosphamide, doxorubicin, vincristine, prednisone ...
Significance of “beta blocker rebound phenomenon” and
... 8. New information about BBs has accumulated over the last years. BBs have profiled according to their pharmacokinetic and pharmacodynamic properties and their widespread availability increases the need for a precise choice [21]. Therefore, one can reasonably hope for new modalities to improve solut ...
... 8. New information about BBs has accumulated over the last years. BBs have profiled according to their pharmacokinetic and pharmacodynamic properties and their widespread availability increases the need for a precise choice [21]. Therefore, one can reasonably hope for new modalities to improve solut ...
2
... management and aberrant behavior such as not taking medications as prescribed, taking additional medications, or illicit drugs. In the effort to provide the highest standard of care for their patients, pain physicians are required to continually assess patients for addiction and, if necessary, refer ...
... management and aberrant behavior such as not taking medications as prescribed, taking additional medications, or illicit drugs. In the effort to provide the highest standard of care for their patients, pain physicians are required to continually assess patients for addiction and, if necessary, refer ...
October 2010 - North Dakota Board of Pharmacy
... to show them the diverse multitude of things we do, we have their ear. WE become their teachers. WE have an opportunity to shape their attitudes. This is the time to show them that a great pharmacy is built on teamwork between the technicians and the pharmacists. That mutual respect for one another ...
... to show them the diverse multitude of things we do, we have their ear. WE become their teachers. WE have an opportunity to shape their attitudes. This is the time to show them that a great pharmacy is built on teamwork between the technicians and the pharmacists. That mutual respect for one another ...
Endo to Acquire Specialty Pharmaceutical Company NuPathe
... Patients should not take ZECUITY if they have heart disease, a history of heart disease or stroke, peripheral vascular disease (narrowing of blood vessels to your legs, arms, stomach or kidney), transient ischemic attack (TIA) or problems with blood circulation, uncontrolled blood pressure, migraine ...
... Patients should not take ZECUITY if they have heart disease, a history of heart disease or stroke, peripheral vascular disease (narrowing of blood vessels to your legs, arms, stomach or kidney), transient ischemic attack (TIA) or problems with blood circulation, uncontrolled blood pressure, migraine ...
Protocols - Olios Health
... 1. The protocols should recognize that the Physician Assistant is acting only on behalf of and as an agent for the supervising physician. 2. Although drugs listed in the formulary may be issued by the P.A. in accordance with the protocols, all drug orders for Schedule II through V controlled substan ...
... 1. The protocols should recognize that the Physician Assistant is acting only on behalf of and as an agent for the supervising physician. 2. Although drugs listed in the formulary may be issued by the P.A. in accordance with the protocols, all drug orders for Schedule II through V controlled substan ...
Colorado Secretary of State
... community should be the primary emphasis in the treatment of lower extremity pain and disability. Currently, practitioners often think of education last, after medications, manual therapy, and surgery. Practitioners must develop and implement an effective strategy and skills to educate patients, emp ...
... community should be the primary emphasis in the treatment of lower extremity pain and disability. Currently, practitioners often think of education last, after medications, manual therapy, and surgery. Practitioners must develop and implement an effective strategy and skills to educate patients, emp ...
Warfarin – indications, risks and drug interactions
... reuptake inhibitors (SSRIs). Alternatively, drugs associated with falls in the elderly (eg. long acting benzodiazepines) can also increase the risk of bleeding with warfarin. Knowledge of such additional side effects of a drug is paramount in predicting interactions with warfarin. ...
... reuptake inhibitors (SSRIs). Alternatively, drugs associated with falls in the elderly (eg. long acting benzodiazepines) can also increase the risk of bleeding with warfarin. Knowledge of such additional side effects of a drug is paramount in predicting interactions with warfarin. ...
Clinical characteristics of patients with vasovagal reactions
... In 1961, Wayne described the features of syncope in 500 cases. In 298 patients, a vasovagal diagnosis was attributed, predominantly due to a history of a specific precipitant[8]. Cases were of all ages and males were more commonly afflicted than females. Precipitants included emotional tension, fatigu ...
... In 1961, Wayne described the features of syncope in 500 cases. In 298 patients, a vasovagal diagnosis was attributed, predominantly due to a history of a specific precipitant[8]. Cases were of all ages and males were more commonly afflicted than females. Precipitants included emotional tension, fatigu ...
New Steps Aimed at Cutting Risks from Acetaminophen
... • took more than the prescribed dose of an acetaminophen-containing product in a 24-hour period • took more than one acetaminophen-containing product at the same time • drank alcohol while taking the drug “There is no immediate danger to patients who take these combination pain medications and th ...
... • took more than the prescribed dose of an acetaminophen-containing product in a 24-hour period • took more than one acetaminophen-containing product at the same time • drank alcohol while taking the drug “There is no immediate danger to patients who take these combination pain medications and th ...
Novel Antipsychotic Agents and Their Implications for Forensic
... is higher than that of clozapine but lower than that of risperidone. with affinity for adrenergic sites, along with a high affinity for the M1 muscarinic and H1 histaminergic receptor^.^^ Studies have shown olanzapine at starting doses of 10 mg per day to be more effective than placebo and as effect ...
... is higher than that of clozapine but lower than that of risperidone. with affinity for adrenergic sites, along with a high affinity for the M1 muscarinic and H1 histaminergic receptor^.^^ Studies have shown olanzapine at starting doses of 10 mg per day to be more effective than placebo and as effect ...
[Product Monograph Template
... Events of blood pressure inadequately controlled were more frequently reported with ivabradine than with placebo (LANCORATM 7.1% versus placebo 6.1%) (see ADVERSE REACTIONS). In hypertensive patients requiring LANCORATM treatment, performance of regular blood pressure monitoring and reassessment of ...
... Events of blood pressure inadequately controlled were more frequently reported with ivabradine than with placebo (LANCORATM 7.1% versus placebo 6.1%) (see ADVERSE REACTIONS). In hypertensive patients requiring LANCORATM treatment, performance of regular blood pressure monitoring and reassessment of ...
Antipsychotics for delirium in the general hospital setting in
... The primary outcome was rates and kinds of serious adverse events. Results: Among 2834 patients who developed delirium, 2453 patients received antipsychotics, such as risperidone (34%), quetiapine (32%), and parenteral haloperidol (20%), for delirium. Out of 2453 patients, 22 serious adverse events ...
... The primary outcome was rates and kinds of serious adverse events. Results: Among 2834 patients who developed delirium, 2453 patients received antipsychotics, such as risperidone (34%), quetiapine (32%), and parenteral haloperidol (20%), for delirium. Out of 2453 patients, 22 serious adverse events ...